Graft-vs-Host Disease (GVHD)

Latest News

October 18th 2024

A Novel Approach to Chronic GVHD With Axatilimab: Dr Daniel Wolff

The latest therapy approved to treat chronic graft-versus-host disease (GVHD) has a new target different than the other approved therapies. Daniel Wolff, MD, also discusses future research on axatilimab to treat chronic GVHD earlier.

A skilled ophthalmologist conducts a thorough ocular examination to assess eye health in a clinical setting | Image Credit: Microgen - stock.adobe.com

March 25th 2024

Amid Search for Biomarkers in oGVHD, Research Focuses on Cytokine Profile of Tears

By AJMC Contributor

GVHD graft vs host disease blood sample | Image Credit: © MdBabul - stock.adobe.com

March 15th 2024

For Chronic GVHD, Second-Line Therapies Vary Widely

By Jared Kaltwasser

GVHD Image| Image Credit: teguhjatipras - stock.adobe.com

March 12th 2024

Review Highlights Role of JAK Inhibition in Advancement of GVHD Prevention, Treatment

By AJMC Contributor

Graft-versus-host disease | Image Credit: Andrii - stock.adobe.codm

March 8th 2024

GVHD Treatment Response at Day 14 as Effective as 28-Day Model, Say Researchers

By AJMC Contributor

ASH 2024 Post Conference Perspectives: Chronic Graft-vs-Host Disease Management

Learn about emerging therapies such as axatilimab, and ibrutinib and rituximab combinations, and how they’re reshaping the treatment landscape for chronic graft-vs-host disease.

Watch Now

ASH 2024 Post Conference Perspectives: Chronic Graft-vs-Host Disease Management

Latest Videos

Analysis Supports Flexible Axatilimab Use in Chronic GVHD, Calls for Combination Therapy Research: Carrie Kitko, MD

Post Hoc Analysis Supports Axatilimab in Heavily Pretreated Patients With Chronic GVHD: Carrie Kitko, MD

CME Content

On-Demand Webinar

Managing Schizophrenia: Evidence-Based Care and Optimizing Value of New and Emerging Therapies

1.0 Credit / Psychiatry

Virtual Symposium

Closing Gaps in CLL Care: Managed Care Insights and Strategies

1.5 Credit / Hematologic Cancer, Oncology

On-Demand Webinar

Revolutionizing Acute Pain Relief: Emerging Non-Opioid Therapies and the Essential Role of Pharmacists

1.5 Credit / Pain Management/Opioids

On-Demand Webinar

Overview and Burden of Migraine

0.5 Credit / Neurology

On-Demand Webinar

The Role of the Pharmacist Migraine Management

0.5 Credit / Neurology

On-Demand Webinar

The Evolving Treatment Landscape of Migraine

0.5 Credit / Neurology

On-Demand Webinar

Evidence-Based Guidelines Point to Leap in Care for Hypertrophic Cardiomyopathy

1.0 Credit / Cardiology

On-Demand Webinar

ASH Annual Meeting Coverage: Highlighting the Recent Updates in TKI Use in the Treatment of CML – Insights and Application for Managed Care

1.0 Credit / Oncology, Hematology, Hematologic Cancer

Online Article

New and Approved: FDA’s 2024 Drug Lineup

1.5 Credits / General Pharmacy

Online Article

Innovations in Medicine: 2024 Lineup of New and Approved Specialty Drugs

2.0 Credits / General Pharmacy

AJMC Supplement

Revolutionizing Acute Pain Relief: Emerging Nonopioid Therapies and the Essential Role of Managed Care

2.0 Credits / Pain Management

On-Demand Virtual Symposium

Leveraging Managed Care to Optimize Patient Outcomes: Integrating Novel Treatments in Schizophrenia

1.5 Credits / Neurology, Psychiatry

On-Demand Virtual Symposium

Advancing Immunotherapy in Endometrial Cancer: A Managed Care Perspective on Personalized Care

1.5 Credits / Gynecologic Cancer, Health Equity, Diversity & Inclusion, Oncology, Women's Health

On-Demand Virtual Symposium

Overcoming Operational and Clinical Barriers in Multiple Myeloma: Managed Care Strategies for Antibody-Based Regimens

1.5 Credits / Hematologic Cancer, Hematology, Oncology

On-Demand Virtual Symposium

Exploring Therapeutic Advances in Myelofibrosis and Key Considerations for Effective Management

1.5 Credits / Oncology, Hematology

On-Demand Virtual Symposium

Driving Better Outcomes in Hypertrophic Cardiomyopathy: A Managed Care Imperative

1.5 Credits / Cardiology

On-Demand Virtual Symposium

Optimizing the Uptake of Long-Acting Injectables in HIV Treatment and Prevention: Considerations for Managed Care

1.5 Credits / HIV/AIDS, Infectious Disease

On-Demand Virtual Symposium

Harnessing Data-Driven Insights and Innovations to Enhance AMD and DME Management: Strategic Approaches for Managed Care

1.5 Credits / Ophthalmology/Optometry

On-Demand Virtual Symposium

Navigating the Advancements in Oral Therapy Options in HR+ Metastatic Breast Cancer

1.5 Credits / Breast Cancer, Oncology, Women's Health

On-Demand Virtual Symposium

Navigating the Changing Treatment Paradigm of Metabolic Dysfunction-Associated Steatohepatitis: A Guide for Managed Care Pharmacists

1.5 Credits / Endocrinology, Diabetes & Metabolism, Gastroenterology

On-Demand Virtual Symposium

Managed Care Approaches and Models for Equitable Access to Innovations in Major Depressive Disorder Treatment

1.5 Credits / Psychiatry

On-Demand Virtual Symposium

Evaluating the Effectiveness and Value of Novel Nonhormonal Treatments in the Management of Menopause-Related Vasomotor Symptoms

1.5 Credits / Women's Health

On-Demand Virtual Symposium

Updated Guidance and Managed Care Strategies to Optimize Respiratory Syncytial Virus Vaccination Coverage

1.5 Credits / Immunization, Infectious Disease, Pulmonology

On-Demand Virtual Symposium

Leveraging Biologics and Immunotherapies in the Management of Food Allergies

1.5 Credits / Immunology, Allergy

On-Demand Virtual Symposium

Advancing Care in Neovascular Age-Related Macular Degeneration and Diabetic Macular Edema: Optimizing Outcomes With Emerging Therapies

1.5 Credits / Ophthalmology/Optometry

On-Demand Virtual Symposium

The Evolving Landscape of Transthyretin Amyloidosis Cardiomyopathy: New Therapies and Treatment Strategies

1.5 Credits / Cardiology, Rare Diseases

On-Demand Virtual Symposium

Reflecting on the Real-World Use of Biologic Therapy in Asthma Management

1.5 Credits / Immunology, Pulmonology

On-Demand Virtual Symposium

Advancing Cystic Fibrosis Management: The Evolving Role of Specialty and Managed Care Pharmacists

1.5 Credits / Pulmonology

On-Demand Virtual Symposium

Pulmonary Arterial Hypertension: Real-World Applications of New Therapies and Management Strategies

1.5 Credits / Pulmonology, Cardiology, Rare Diseases

On-Demand Virtual Symposium

Targeting Chronic Rhinosinusitis With Nasal Polyps With Biologics: Optimizing Outcomes and Reducing Health Care Burden

1.5 Credits / Immunology

On-Demand Virtual Symposium

Emerging Treatment Options for Inflammatory Bowel Disease: A Focus on IL-23 Pathway Inhibition

1.5 Credits / Gastroenterology, Immunology

On-Demand Virtual Symposium

Transforming Metabolic Dysfunction-Associated Steatohepatitis Management: Pharmacist Considerations for the Evolving Treatment Landscape

1.5 Credits / Gastroenterology

On-Demand Webinar

Innovations in Inflammatory Bowel Disease Therapy: How IL-23 Inhibitors Are Shaping Treatment and Managed Care Approaches

1.5 Credits / Gastroenterology, Immunology

On-Demand Webinar

The Expanding Therapeutic Landscape in IgA Nephropathy: Applying Evidence-Based Strategies and Guideline Updates for Managed Care

1.0 Credit / Immunology, Nephrology

On-Demand Webinar

Leveraging Novel Therapies to Transform Demodex Blepharitis Care (Pharmacy Technician Credit)

1.5 Credit / Ophthalmology/Optometry

On-Demand Webinar

Leveraging Novel Therapies to Transform Demodex Blepharitis Care

1.5 Credit / Ophthalmology/Optometry

On-Demand Webinar

The Changing Paradigm in Pain Management and Supporting Access to Novel Therapies

1.0 Credit / Pain Management/Opioids

On-Demand Webinar

The Expanding Therapeutic Landscape in IgA Nephropathy: A Case-Based Exploration of Optimized Patient Outcomes

1.0 Credit / Immunology, Nephrology

On-Demand Webinar

Opioids, Pain Management, and Substance Use Disorder: A Practical Overview

2.0 Credits / Pain Management/Opioids

More News

Patient speaking with doctor | Image credit: DragonImages - adobe.stock.com

PROs May Successfully Risk Stratify Patients With Cutaneous Chronic GVHD

ByLaura Joszt, MA

March 1st 2024

Two existing, well-validated patient-reported outcome (PRO) measures may be useful as a prognostic marker for mortality and assist with treatment selection for patients with cutaneous chronic graft-vs-host disease (GVHD).

Understanding AGAVE-201 and Unmet Need in Chronic GVHD

ByProduced by Mary Caffrey

January 6th 2024

GVHD May Mimic Eosinophilic GI Disorders Following Bone Marrow Transplant

ByRose McNulty

July 30th 2022

After years of dependence on systemic corticosteroids, ruxolitinib treatment was effective for an adolescent patient with graft-versus-host disease (GVHD) who was initially thought to have eosinophilic gastroenteritis.

Graft-vs-Host Disease (GVHD)

Latest News

ASH 2024 Post Conference Perspectives: Chronic Graft-vs-Host Disease Management

Latest Videos

Analysis Supports Flexible Axatilimab Use in Chronic GVHD, Calls for Combination Therapy Research: Carrie Kitko, MD

Post Hoc Analysis Supports Axatilimab in Heavily Pretreated Patients With Chronic GVHD: Carrie Kitko, MD

CME Content

Managing Schizophrenia: Evidence-Based Care and Optimizing Value of New and Emerging Therapies

Closing Gaps in CLL Care: Managed Care Insights and Strategies

Revolutionizing Acute Pain Relief: Emerging Non-Opioid Therapies and the Essential Role of Pharmacists

Overview and Burden of Migraine

The Role of the Pharmacist Migraine Management

The Evolving Treatment Landscape of Migraine

Evidence-Based Guidelines Point to Leap in Care for Hypertrophic Cardiomyopathy

ASH Annual Meeting Coverage: Highlighting the Recent Updates in TKI Use in the Treatment of CML – Insights and Application for Managed Care

New and Approved: FDA’s 2024 Drug Lineup

Innovations in Medicine: 2024 Lineup of New and Approved Specialty Drugs

Revolutionizing Acute Pain Relief: Emerging Nonopioid Therapies and the Essential Role of Managed Care

Leveraging Managed Care to Optimize Patient Outcomes: Integrating Novel Treatments in Schizophrenia

Advancing Immunotherapy in Endometrial Cancer: A Managed Care Perspective on Personalized Care

Overcoming Operational and Clinical Barriers in Multiple Myeloma: Managed Care Strategies for Antibody-Based Regimens

Exploring Therapeutic Advances in Myelofibrosis and Key Considerations for Effective Management

Driving Better Outcomes in Hypertrophic Cardiomyopathy: A Managed Care Imperative

Optimizing the Uptake of Long-Acting Injectables in HIV Treatment and Prevention: Considerations for Managed Care

Harnessing Data-Driven Insights and Innovations to Enhance AMD and DME Management: Strategic Approaches for Managed Care

Navigating the Advancements in Oral Therapy Options in HR+ Metastatic Breast Cancer

Navigating the Changing Treatment Paradigm of Metabolic Dysfunction-Associated Steatohepatitis: A Guide for Managed Care Pharmacists

Managed Care Approaches and Models for Equitable Access to Innovations in Major Depressive Disorder Treatment

Evaluating the Effectiveness and Value of Novel Nonhormonal Treatments in the Management of Menopause-Related Vasomotor Symptoms

Updated Guidance and Managed Care Strategies to Optimize Respiratory Syncytial Virus Vaccination Coverage

Leveraging Biologics and Immunotherapies in the Management of Food Allergies

Advancing Care in Neovascular Age-Related Macular Degeneration and Diabetic Macular Edema: Optimizing Outcomes With Emerging Therapies

The Evolving Landscape of Transthyretin Amyloidosis Cardiomyopathy: New Therapies and Treatment Strategies

Reflecting on the Real-World Use of Biologic Therapy in Asthma Management

Advancing Cystic Fibrosis Management: The Evolving Role of Specialty and Managed Care Pharmacists

Pulmonary Arterial Hypertension: Real-World Applications of New Therapies and Management Strategies

Targeting Chronic Rhinosinusitis With Nasal Polyps With Biologics: Optimizing Outcomes and Reducing Health Care Burden

Emerging Treatment Options for Inflammatory Bowel Disease: A Focus on IL-23 Pathway Inhibition

Transforming Metabolic Dysfunction-Associated Steatohepatitis Management: Pharmacist Considerations for the Evolving Treatment Landscape

Innovations in Inflammatory Bowel Disease Therapy: How IL-23 Inhibitors Are Shaping Treatment and Managed Care Approaches

The Expanding Therapeutic Landscape in IgA Nephropathy: Applying Evidence-Based Strategies and Guideline Updates for Managed Care

Leveraging Novel Therapies to Transform Demodex Blepharitis Care (Pharmacy Technician Credit)

Leveraging Novel Therapies to Transform Demodex Blepharitis Care

The Changing Paradigm in Pain Management and Supporting Access to Novel Therapies

The Expanding Therapeutic Landscape in IgA Nephropathy: A Case-Based Exploration of Optimized Patient Outcomes

Opioids, Pain Management, and Substance Use Disorder: A Practical Overview

More News

PROs May Successfully Risk Stratify Patients With Cutaneous Chronic GVHD

Understanding AGAVE-201 and Unmet Need in Chronic GVHD

GVHD May Mimic Eosinophilic GI Disorders Following Bone Marrow Transplant

Trending on AJMC

Promises and Pitfalls of AI in Health Care

Texas Sues J&J, Kenvue for Alleged Deception in Acetaminophen Marketing

SCRI’s Vivek Subbiah, MD, Highlights Trials on Tumor-Agnostic Cancer Therapies During ESMO

With New OUD Diagnoses on the Rise, More Comprehensive Screenings Needed

Energy Insecurity Linked to Higher Depression, Anxiety in US Adults